(Q46568973)

English

Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

1 reference

based on heuristic

inferred from title

breast carcinoma

1 reference

based on heuristic

inferred from title

Francisco J Esteva

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Gabriel N Hortobagyi

9

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

3

object named as

K Kian Ang

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

S. Eva Singletary

8

object named as

S Eva Singletary

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

author name string

Thomas A Buchholz

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Xiaoyu Tu

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Henry M Kuerer

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Lajos Pusztai

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Massimo Cristofanilli

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Aysegul A Sahin

10

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

104

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

676-681

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Signal transduction and oncogenesis by ErbB/HER receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR overexpression and radiation response in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21217

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21217

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15981280

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46568973&oldid=2121302674"